|
Five Changes are Key to FDA Innovation in Drug Evaluation
In addition to the issues facing drug discovery and development, critical challenges related to drug evaluation must be addressed to advance innovation to serve public health needs.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives